Corinne H. Nevinny, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 5,000 shares at $132.63 ($663K) on 2013-07-01, disclosed to the SEC on 2013-07-02.
Scheduled sale ($663k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $132.63 | 2,000 | $265K | 40.0% |
| 2 | $132.63 | 3,000 | $398K | 60.0% |
| Total | $132.63 avg | 5,000 | $663K | 100% |
| Filing → |
| NBIX | SELL | 2018-05-09 | $416K | — | Filing → |
| NBIX | SELL | 2017-05-08 | $270K | — | Filing → |
| NBIX | SELL | 2016-08-09 | $243K | — | Filing → |